CBIO Insider Transactions
| Transaction Date (SEC Report ) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price() | Amount() |
|---|---|---|---|---|---|---|---|---|
| 2022-08-09 | Blouse Grant E. | officer: Chief Scientific Officer | 9,417 | P-Purchase | A | 3,250 | 0.47 | 1,527.50 |
| 2022-08-09 | Miller Seline E. | officer: SVP Finance; Interim CFO & PAO | 6,500 | P-Purchase | A | 3,250 | 0.47 | 1,527.50 |
| 2022-08-09 | USMAN NASSIM | director, officer: President & CEO | 24,541 | P-Purchase | A | 3,250 | 0.47 | 1,527.50 |
| 2022-02-11 | Blouse Grant E. | officer: Chief Scientific Officer | 200,000 | A-Award | A | 200,000 | 0.52 | 104,000.00 |
| 2022-02-11 | Miller Seline E. | officer: SVP Finance; Interim CFO & PAO | 107,500 | A-Award | A | 107,500 | 0.52 | 55,900.00 |
| 2022-02-09 | USMAN NASSIM | director, officer: President & CEO | 21,291 | P-Purchase | A | 3,250 | 0.46 | 1,495.00 |
| 2022-02-09 | Miller Seline E. | officer: SVP Finance; Interim CFO & PAO | 3,250 | P-Purchase | A | 3,250 | 0.46 | 1,495.00 |
| 2022-02-09 | Blouse Grant E. | officer: Chief Scientific Officer | 6,167 | P-Purchase | A | 3,250 | 0.46 | 1,495.00 |
| 2022-01-07 | Williams Eddie | director | 34,804 | A-Award | A | 12,308 | 0.00 | 0.00 |
| 2022-01-07 | Hunt Andrea | director | 28,228 | A-Award | A | 7,521 | 0.00 | 0.00 |
| 2022-01-07 | Ling Geoffrey M.D. | director | 31,790 | A-Award | A | 12,855 | 0.00 | 0.00 |
| 2021-10-01 | DESOUZA ERROL B | director | 29,801 | A-Award | A | 3,588 | 0.00 | 0.00 |
| 2021-10-01 | Hunt Andrea | director | 20,707 | A-Award | A | 1,824 | 0.00 | 0.00 |
| 2021-10-01 | LAWLOR AUGUSTINE | director | 24,573 | A-Award | A | 5,839 | 0.00 | 0.00 |
| 2021-10-01 | Ling Geoffrey M.D. | director | 18,935 | A-Award | A | 2,858 | 0.00 | 0.00 |
| 2021-10-01 | Williams Eddie | director | 22,496 | A-Award | A | 2,980 | 0.00 | 0.00 |
| 2021-09-09 | JEW JEANNE Y | director | 28,000 | A-Award | A | 28,000 | 4.38 | 122,640.00 |
| 2021-08-09 | Blouse Grant E. | officer: Chief Scientific Officer | 2,917 | P-Purchase | A | 1,163 | 3.62 | 4,210.06 |
| 2021-08-09 | Levy Howard | officer: Chief Medical Officer | 639 | P-Purchase | A | 639 | 3.62 | 2,313.18 |
| 2021-08-09 | USMAN NASSIM | director, officer: President & CEO | 18,041 | P-Purchase | A | 867 | 3.62 | 3,138.54 |
| 2021-07-01 | DESOUZA ERROL B | director | 26,213 | A-Award | A | 3,406 | 0.00 | 0.00 |
| 2021-07-01 | Williams Eddie | director | 19,516 | A-Award | A | 1,414 | 0.00 | 0.00 |
| 2021-07-01 | Ling Geoffrey M.D. | director | 16,077 | A-Award | A | 2,713 | 0.00 | 0.00 |
| 2021-07-01 | LAWLOR AUGUSTINE | director | 18,734 | A-Award | A | 5,542 | 0.00 | 0.00 |
| 2021-07-01 | Hunt Andrea | director | 18,883 | A-Award | A | 2,886 | 0.00 | 0.00 |
| 2021-06-09 | TETLOW SHARON | director | 14,000 | A-Award | A | 14,000 | 4.55 | 63,700.00 |
| 2021-06-09 | DESOUZA ERROL B | director | 14,000 | A-Award | A | 14,000 | 4.55 | 63,700.00 |
| 2021-06-09 | Williams Eddie | director | 14,000 | A-Award | A | 14,000 | 4.55 | 63,700.00 |
| 2021-06-09 | Ling Geoffrey M.D. | director | 14,000 | A-Award | A | 14,000 | 4.55 | 63,700.00 |
| 2021-06-09 | LAWLOR AUGUSTINE | director | 14,000 | A-Award | A | 14,000 | 4.55 | 63,700.00 |
| 2021-06-09 | Hunt Andrea | director | 14,000 | A-Award | A | 14,000 | 4.55 | 63,700.00 |
| 2021-04-05 | USMAN NASSIM | director, officer: President & CEO | 17,174 | M-Exempt | A | 5,000 | 4.63 | 23,150.00 |
| 2021-04-05 | USMAN NASSIM | director, officer: President & CEO | 259,783 | M-Exempt | D | 5,000 | 4.63 | 23,150.00 |
| 2021-04-01 | DESOUZA ERROL B | director | 22,807 | A-Award | A | 2,926 | 0.00 | 0.00 |
| 2021-04-01 | Williams Eddie | director | 18,102 | A-Award | A | 1,215 | 0.00 | 0.00 |
| 2021-04-01 | Ling Geoffrey M.D. | director | 13,364 | A-Award | A | 2,331 | 0.00 | 0.00 |
| 2021-04-01 | LAWLOR AUGUSTINE | director | 13,192 | A-Award | A | 4,761 | 0.00 | 0.00 |
| 2021-04-01 | Hunt Andrea | director | 15,997 | A-Award | A | 2,480 | 0.00 | 0.00 |
| 2021-02-09 | Levy Howard | officer: Chief Medical Officer | 23,390 | P-Purchase | A | 1,670 | 4.81 | 8,032.70 |
| 2021-02-09 | USMAN NASSIM | director, officer: President & CEO | 12,174 | P-Purchase | A | 582 | 4.81 | 2,799.42 |
| 2021-02-08 | Levy Howard | officer: Chief Medical Officer | 25,000 | A-Award | A | 25,000 | 5.89 | 147,250.00 |
| 2021-02-08 | Musil Clinton | officer: Chief Financial Officer | 54,000 | A-Award | A | 54,000 | 5.89 | 318,060.00 |
| 2021-02-08 | USMAN NASSIM | director, officer: President & CEO | 140,000 | A-Award | A | 140,000 | 5.89 | 824,600.00 |
| 2021-01-05 | Ling Geoffrey M.D. | director | 11,033 | A-Award | A | 1,782 | 0.00 | 0.00 |
| 2021-01-05 | LAWLOR AUGUSTINE | director | 8,431 | A-Award | A | 3,417 | 0.00 | 0.00 |
| 2021-01-05 | Williams Eddie | director | 16,887 | A-Award | A | 940 | 0.00 | 0.00 |
| 2021-01-05 | Hunt Andrea | director | 13,517 | A-Award | A | 1,881 | 0.00 | 0.00 |
| 2021-01-05 | DESOUZA ERROL B | director | 19,881 | A-Award | A | 2,129 | 0.00 | 0.00 |
| 2020-10-01 | DESOUZA ERROL B | director | 17,752 | A-Award | A | 3,125 | 0.00 | 0.00 |
| 2020-10-01 | Williams Eddie | director | 15,947 | A-Award | A | 1,380 | 0.00 | 0.00 |
| 2020-10-01 | Ling Geoffrey M.D. | director | 9,251 | A-Award | A | 2,616 | 0.00 | 0.00 |
| 2020-10-01 | LAWLOR AUGUSTINE | director | 5,014 | A-Award | A | 5,014 | 0.00 | 0.00 |
| 2020-10-01 | Hunt Andrea | director | 11,636 | A-Award | A | 2,761 | 0.00 | 0.00 |
| 2020-08-10 | USMAN NASSIM | director, officer: President & CEO | 11,592 | P-Purchase | A | 582 | 4.81 | 2,799.42 |
| 2020-08-10 | Levy Howard | officer: Chief Medical Officer | 4,268 | P-Purchase | A | 1,768 | 4.81 | 8,504.08 |
| 2020-07-01 | DESOUZA ERROL B | director | 14,627 | A-Award | A | 2,129 | 0.00 | 0.00 |
| 2020-07-01 | Hunt Andrea | director | 8,875 | A-Award | A | 2,076 | 0.00 | 0.00 |
| 2020-07-01 | LAWLOR AUGUSTINE | director | 24,215 | A-Award | A | 3,673 | 0.00 | 0.00 |
| 2020-07-01 | Ling Geoffrey M.D. | director | 6,635 | A-Award | A | 1,703 | 0.00 | 0.00 |
| 2020-07-01 | Williams Eddie | director | 14,567 | A-Award | A | 1,011 | 0.00 | 0.00 |
| 2020-07-01 | Musil Clinton | officer: Chief Financial Officer | 140,000 | A-Award | A | 140,000 | 5.88 | 823,200.00 |
| 2020-07-01 | TETLOW SHARON | director | 3,635 | A-Award | A | 1,703 | 0.00 | 0.00 |
| 2020-06-11 | Hunt Andrea | director | 5,000 | A-Award | A | 5,000 | 7.18 | 35,900.00 |
| 2020-06-11 | Williams Eddie | director | 5,000 | A-Award | A | 5,000 | 7.18 | 35,900.00 |
| 2020-06-11 | TETLOW SHARON | director | 5,000 | A-Award | A | 5,000 | 7.18 | 35,900.00 |
| 2020-06-11 | Ling Geoffrey M.D. | director | 5,000 | A-Award | A | 5,000 | 7.18 | 35,900.00 |
| 2020-06-11 | DESOUZA ERROL B | director | 5,000 | A-Award | A | 5,000 | 7.18 | 35,900.00 |
| 2020-06-11 | LAWLOR AUGUSTINE | director | 5,000 | A-Award | A | 5,000 | 7.18 | 35,900.00 |
| 2020-04-01 | Hunt Andrea | director | 6,799 | A-Award | A | 1,673 | 0.00 | 0.00 |
| 2020-04-01 | Ling Geoffrey M.D. | director | 4,932 | A-Award | A | 1,932 | 0.00 | 0.00 |
| 2020-04-01 | Williams Eddie | director | 13,556 | A-Award | A | 2,717 | 0.00 | 0.00 |
| 2020-04-01 | DESOUZA ERROL B | director | 12,498 | A-Award | A | 2,860 | 0.00 | 0.00 |
| 2020-04-01 | LAWLOR AUGUSTINE | director | 20,542 | A-Award | A | 4,934 | 0.00 | 0.00 |
| 2020-04-01 | TETLOW SHARON | director | 1,932 | A-Award | A | 1,932 | 0.00 | 0.00 |
| 2020-03-16 | Levy Howard | officer: Chief Medical Officer | 2,500 | P-Purchase | A | 2,500 | 4.05 | 10,131.50 |
| 2020-03-13 | Cai Veronica | officer: Controller | 7,353 | P-Purchase | A | 2,000 | 4.11 | 8,220.00 |
| 2020-03-13 | Richard John P | director | 3,716 | P-Purchase | A | 2,500 | 3.98 | 9,950.00 |
| 2020-03-13 | USMAN NASSIM | director, officer: President & CEO | 11,010 | P-Purchase | A | 4,000 | 3.91 | 15,647.20 |
| 2020-03-04 | Williams Eddie | director | 10,839 | P-Purchase | A | 2,000 | 5.78 | 11,560.00 |
| 2020-02-25 | LAWLOR AUGUSTINE | director | 0 | S-Sale | D | 69,401 | 6.10 | 423,505.72 |
| 2020-02-25 | Ling Geoffrey M.D. | director | 3,000 | P-Purchase | A | 3,000 | 6.23 | 18,691.50 |
| 2020-02-10 | Cai Veronica | officer: Controller | 5,353 | A-Award | A | 1,678 | 6.23 | 10,453.94 |
| 2020-02-10 | Levy Howard | officer: Chief Medical Officer | 1,358 | A-Award | A | 1,358 | 6.23 | 8,460.34 |
| 2020-02-10 | USMAN NASSIM | director, officer: President & CEO | 7,010 | A-Award | A | 430 | 6.23 | 2,678.90 |
| 2020-01-23 | USMAN NASSIM | director, officer: President & CEO | 115,000 | A-Award | A | 115,000 | 6.85 | 787,750.00 |
| 2020-01-23 | Cai Veronica | officer: Controller | 12,000 | A-Award | A | 12,000 | 6.85 | 82,200.00 |
| 2020-01-23 | Levy Howard | officer: Chief Medical Officer | 45,000 | A-Award | A | 45,000 | 6.85 | 308,250.00 |
| 2020-01-15 | TETLOW SHARON | director | 10,000 | A-Award | A | 10,000 | 7.29 | 72,900.00 |
| 2020-01-15 | Ling Geoffrey M.D. | director | 10,000 | A-Award | A | 10,000 | 7.29 | 72,900.00 |
| 2020-01-02 | Williams Eddie | director | 8,839 | A-Award | A | 1,743 | 0.00 | 0.00 |
| 2020-01-02 | DESOUZA ERROL B | director | 9,638 | A-Award | A | 1,835 | 0.00 | 0.00 |
| 2020-01-02 | Hunt Andrea | director | 5,126 | A-Award | A | 1,073 | 0.00 | 0.00 |
| 2020-01-02 | LAWLOR AUGUSTINE | director | 15,608 | A-Award | A | 3,166 | 0.00 | 0.00 |
| 2019-10-01 | LAWLOR AUGUSTINE | director | 12,442 | A-Award | A | 4,391 | 0.00 | 0.00 |
| 2019-10-01 | Hunt Andrea | director | 4,053 | A-Award | A | 1,489 | 0.00 | 0.00 |
| 2019-10-01 | DESOUZA ERROL B | director | 7,803 | A-Award | A | 2,545 | 0.00 | 0.00 |
| 2019-10-01 | Williams Eddie | director | 7,096 | A-Award | A | 2,418 | 0.00 | 0.00 |
| 2019-09-16 | Cai Veronica | officer: Controller | 3,000 | A-Award | A | 3,000 | 6.22 | 18,660.00 |
| 2019-08-12 | Payne Fletcher | officer: Chief Financial Officer | 3,744 | A-Award | A | 1,180 | 6.51 | 7,681.80 |
| 2019-08-12 | USMAN NASSIM | director, officer: President & CEO | 6,580 | A-Award | A | 413 | 0.00 | 0.00 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Group doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Group or anyone involved with Discounting Cash Flows Group will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.